Cimpress Analyst Price Targets

Wall Street analyst price targets and consensus rating for Cimpress (CMPR).

Price Target Range — 11 Quarters

Analyst Consensus — 2 Analysts

2Buy

Consensus RatingOutperform# Analysts2Avg. Consensus PT$111Upside to Avg. PT+47.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 31, 2026	Truist Securities	Youssef Squali	PT Cut	Buy	$110→$108
May 6, 2026	Barrington Research	Kevin Steinke	PT Raise	Outperform	$95→$113
Feb 2, 2026	Barrington Research	Kevin Steinke	PT Raise	Outperform	$83→$95
Jan 27, 2026	Barrington Research	Kevin Steinke	Maintained	Outperform	$83
Nov 17, 2025	Barrington Research	Kevin Steinke	PT Raise	Outperform	$77→$83
Oct 1, 2025	Barrington Research	Kevin Steinke	PT Raise	Outperform	$70→$77
Sep 17, 2025	Truist Securities	Youssef Squali	PT Raise	Buy	$74→$78
Aug 4, 2025	Barrington Research	Kevin Steinke	PT Raise	Outperform	$65→$70
Jul 30, 2025	Truist Securities	Youssef Squali	PT Raise	Buy	$60→$74
Jul 29, 2025	Barrington Research	Kevin Steinke	Maintained	Outperform	$65
May 9, 2025	Barrington Research	Kevin Steinke	PT Cut	Outperform	$95→$65
May 5, 2025	Truist Securities	Youssef Squali	PT Cut	Buy	$87→$60
Jan 31, 2025	Truist Securities	Youssef Squali	PT Cut	Buy	$110→$87
Jan 31, 2025	Barrington Research	Kevin Steinke	PT Cut	Outperform	$119→$95
Jan 29, 2025	Barrington Research	Kevin Steinke	Maintained	Outperform	$119
Dec 20, 2024	Barrington Research	Kevin Steinke	Maintained	Outperform	$119
Nov 1, 2024	Truist Securities	Youssef Squali	PT Cut	Buy	$120→$110
Aug 27, 2024	Barrington Research	Kevin Steinke	PT Raise	Outperform	$113→$119
Aug 2, 2024	Truist Securities	Youssef Squali	PT Raise	Buy	$110→$120
May 28, 2024	Barrington Research	Kevin Steinke	Maintained	Outperform	$113

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Truist Securities Maintains Buy on Cimpress, Lowers Price Target to $108

Truist Securities analyst Youssef Squali maintains Cimpress (NASDAQ:CMPR) with a Buy and lowers the price target from $110 to $108.

Benzinga Newsdesk

PRO
Barrington Research Maintains Outperform on Cimpress, Raises Price Target to $113

Barrington Research analyst Kevin Steinke maintains Cimpress (NASDAQ:CMPR) with a Outperform and raises the price target from $95 to $113.

Benzinga Newsdesk

PRO
Barrington Research Maintains Outperform on Cimpress, Raises Price Target to $95

Barrington Research analyst Kevin Steinke maintains Cimpress (NASDAQ:CMPR) with a Outperform and raises the price target from $83 to $95.

Benzinga Newsdesk

PRO
Barrington Research Maintains Outperform on Cimpress, Maintains $83 Price Target

Barrington Research analyst Kevin Steinke maintains Cimpress (NASDAQ:CMPR) with a Outperform and maintains $83 price target.

Benzinga Newsdesk

PRO
Barrington Research Maintains Outperform on Cimpress, Raises Price Target to $83

Barrington Research analyst Kevin Steinke maintains Cimpress (NASDAQ:CMPR) with a Outperform and raises the price target from $77 to $83.

Benzinga Newsdesk

Boston Scientific To Rally More Than 35%? Here Are 10 Top Analyst Forecasts For Wednesday

Avi Kapoor

Cimpress PLC

Cimpress Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Truist Securities Maintains Buy on Cimpress, Lowers Price Target to $108

PRO
Barrington Research Maintains Outperform on Cimpress, Raises Price Target to $113

PRO
Barrington Research Maintains Outperform on Cimpress, Raises Price Target to $95

PRO
Barrington Research Maintains Outperform on Cimpress, Maintains $83 Price Target

PRO
Barrington Research Maintains Outperform on Cimpress, Raises Price Target to $83

Boston Scientific To Rally More Than 35%? Here Are 10 Top Analyst Forecasts For Wednesday

People Also Watch

People Also Watch

Cimpress PLC

Cimpress Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROTruist Securities Maintains Buy on Cimpress, Lowers Price Target to $108

PROBarrington Research Maintains Outperform on Cimpress, Raises Price Target to $113

PROBarrington Research Maintains Outperform on Cimpress, Raises Price Target to $95

PROBarrington Research Maintains Outperform on Cimpress, Maintains $83 Price Target

PROBarrington Research Maintains Outperform on Cimpress, Raises Price Target to $83

Boston Scientific To Rally More Than 35%? Here Are 10 Top Analyst Forecasts For Wednesday

People Also Watch

People Also Watch

PRO
Truist Securities Maintains Buy on Cimpress, Lowers Price Target to $108

PRO
Barrington Research Maintains Outperform on Cimpress, Raises Price Target to $113

PRO
Barrington Research Maintains Outperform on Cimpress, Raises Price Target to $95

PRO
Barrington Research Maintains Outperform on Cimpress, Maintains $83 Price Target

PRO
Barrington Research Maintains Outperform on Cimpress, Raises Price Target to $83